局所麻酔薬の世界市場レポート 2025年

局所麻酔薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.9％で59億6,000万米ドルに成長します。予測期間の成長は、外来手術センター（ASC）の増加、新興市場、個別化医療の採用、薬剤の再利用、費用対効果、世界の健康危機への対応などに起因しています。予測期間における世界の動向には、技術の進歩、市場の統合と提携、患者の安全性と快適性の重視、規制状況、世界市場の成長などが含まれます。

外科手術の拡大が局所麻酔薬市場を牽引すると予測されます。外科手術は、傷害や疾病の物理的治療に取り組む医療分野であり、心血管疾患、がん、整形外科疾患などの偶発的かつ持続的な症状のために世界的に増加傾向にあります。このような手術の急増は、これらの処置に不可欠な局所麻酔薬の需要をエスカレートさせています。例えば、国立医学図書館の予測によると、心臓血管外科手術は2040年までに15,501件に達し、2019年の4.3％から46.5％急増すると予想されています。したがって、手術の急増は局所麻酔薬市場に大きな影響を与えます。

慢性疾患の有病率の上昇は、今後数年間の局所麻酔薬市場の成長を促進すると予測されています。慢性疾患とは、3カ月以上持続し、時間の経過とともに悪化する病気と定義されます。これらの疾患は外科的介入を必要とすることが多いため、局所麻酔薬の需要が高まっています。これらの薬剤は、慢性疾患に関連する手術中の疼痛管理に不可欠であり、患者の快適性を確保します。高齢化、手術技術の進歩、外来手術の重視といった要因が、局所麻酔薬の需要をさらに押し上げています。例えば、2022年1月、米国を拠点とするがん啓発の非営利団体である米国がん協会（American Cancer Society）は、米国における新たながん患者数は約190万人、がん関連死亡者数は609,360人と推定しており、1日当たり約1,670人が死亡していることになります。このように、慢性疾患の増加が局所麻酔薬市場の拡大を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の局所麻酔薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の局所麻酔薬市場：成長率分析
• 世界の局所麻酔薬市場の実績：規模と成長, 2019-2024
• 世界の局所麻酔薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の局所麻酔薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の局所麻酔薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブピバカイン
• リドカイン
• ベンゾカイン
• ロピバカイン
• プリロカイン
• クロロプロカイン
• その他のタイプ
• 世界の局所麻酔薬市場：投与方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射可能
• 表面麻酔
• 世界の局所麻酔薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 薬局
• その他のチャンネル
• 世界の局所麻酔薬市場：ブピバカインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 局所用製剤
• 世界の局所麻酔薬市場：リドカインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 局所用製剤
• 経皮パッチ
• 世界の局所麻酔薬市場：ベンゾカインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外用ジェル
• 軟膏
• ロゼンジ
• 世界の局所麻酔薬市場：ロピバカインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 世界の局所麻酔薬市場：プリロカインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 局所用製剤
• 世界の局所麻酔薬市場：クロロプロカインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 世界の局所麻酔薬市場：その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• テトラカイン
• プロカイン
• アルチカイン

第7章 地域別・国別分析

• 世界の局所麻酔薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の局所麻酔薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 局所麻酔薬市場：競合情勢
• 局所麻酔薬市場：企業プロファイル
  • Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Glenmark Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • Pacira BioSciences Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• Septodont
• Teva Pharmaceutical Industries Limited
• Aspen Pharmacare Holdings Limited
• Sagent Pharmaceuticals Inc.
• Mylan N.V.
• Akorn Operating Company LLC
• Endo International PLC
• Abbott Laboratories
• Anesiva Inc.
• Baxter International Inc.
• Dentsply Sirona Inc.
• Jiangsu Hengrui Medicine Co. Ltd.
• Johnson & Johnson
• Lannett Company Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 局所麻酔薬市場2029：新たな機会を提供する国
• 局所麻酔薬市場2029：新たな機会を提供するセグメント
• 局所麻酔薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Local anesthesia medications serve as a pain management solution during minor procedures, targeting specific areas to numb potential pain. These drugs, categorized as local anesthetics, work by suppressing nociceptors, the pain receptors, thereby preventing them from transmitting pain signals to the brain.

Key local anesthesia drugs include bupivacaine, lidocaine, benzocaine, ropivacaine, prilocaine, chloroprocaine, among others. Bupivacaine, a local anesthetic with the chemical formula C18H28N2O, shares similarities with lidocaine but has a longer-lasting effect. These drugs are commonly available in injectable and surface anesthetic forms, distributed through hospital pharmacies, retail pharmacy outlets, and various other distribution channels.

The local anesthesia drugs market research report is one of a series of new reports from The Business Research Company that provides local anesthesia drugs market statistics, including local anesthesia drugs industry global market size, regional shares, competitors with a local anesthesia drugs market share, detailed local anesthesia drugs market segments, market trends and opportunities, and any further data you may need to thrive in the local anesthesia drugs industry. This local anesthesia drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The local anesthesia drugs market size has grown strongly in recent years. It will grow from $4.48 billion in 2024 to $4.73 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to surgical procedures growth, aging population, rising awareness, regulatory environment, economic factors, patient preferences evolution.

The local anesthesia drugs market size is expected to see strong growth in the next few years. It will grow to $5.96 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing ambulatory surgical centers (ASCs), emerging markets, personalized medicine adoption, drug repurposing, cost-effectiveness, global health crises response. Major trends in the forecast period include technological advancements, market consolidation and partnerships, focus on patient safety and comfort, regulatory landscape, global market growth.

The expansion in surgical procedures is anticipated to drive the local anesthesia drugs market forward. Surgery, a medical field addressing physical treatments for injuries and illnesses, is on the rise globally due to incidents and persistent conditions like cardiovascular diseases, cancers, and orthopedic ailments. This surge in surgeries escalates the demand for local anesthesia drugs, integral to these procedures. For instance, as per the National Library of Medicine, the projection expects cardiovascular surgeries to reach 15,501 cases by 2040, a 46.5% surge from 2019's count of 4.3%. Hence, the upsurge in surgeries significantly influences the local anesthesia drugs market.

The rising prevalence of chronic diseases is projected to drive the growth of the local anesthesia drugs market in the coming years. Chronic diseases are defined as illnesses that persist for three months or longer and may worsen over time. These conditions frequently require surgical interventions, leading to a higher demand for local anesthesia drugs. These medications are vital for managing pain during surgeries related to chronic diseases, ensuring patient comfort. Factors such as an aging population, advancements in surgical techniques, and an emphasis on outpatient surgeries further boost the demand for local anesthesia drugs. For example, in January 2022, the American Cancer Society, a US-based cancer awareness non-profit organization, estimated that there would be approximately 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States, translating to about 1,670 deaths per day. Thus, the increasing prevalence of chronic diseases is driving the expansion of the local anesthesia drugs market.

Key players in the local anesthesia drugs market are focusing on developing ready-to-use formulations to maintain their competitive edge. These formulations refer to pre-prepared solutions or mixtures that are conveniently packaged and require no additional processing, thereby streamlining the administration of anesthesia during medical procedures. For example, Baxter International Inc., a US-based healthcare company, introduced Ropivacaine Hydrochloride Injection, which comes in ready-to-use, single-dose infusion bags available in 200 mg/100 mL and 400 mg/200 mL strengths. Ropivacaine is utilized in adults for local or regional anesthesia during surgical procedures and for managing acute pain. This product is designed to provide efficient and effective pain relief in clinical environments.

Leading companies in the local anesthesia drugs market are focusing on the development of dual-acting local anesthetics to strengthen their market position. A dual-acting local anesthetic works by blocking sensory nerves to numb the targeted area while also providing anti-inflammatory effects or prolonged numbness. This combination enhances its efficacy for surgical procedures and acute pain management. For example, in January 2024, Heron Therapeutics, Inc., a US-based biotechnology firm, launched ZYNRELEF, which has received FDA approval. This product combines bupivacaine with a low dose of meloxicam for improved pain relief, effectively reducing pain and minimizing the need for opioids in patients for up to 72 hours post-surgery, as shown in Phase 3 studies.

In January 2022, Dechra Pharmaceuticals, a UK-based pharmaceutical company, acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic from Halocarbon Life Sciences for an undisclosed amount. This acquisition allows Dechra to strengthen its presence in the veterinary market by offering high-quality anesthetic options for surgical procedures. This strategy is in line with their objective of enhancing their companion animal portfolio across various therapeutic areas, including endocrinology, dermatology, and pain management. Halocarbon Life Sciences is a US-based manufacturer of local anesthesia drugs.

Major companies operating in the local anesthesia drugs market are Hikma Pharmaceuticals PLC, Fresenius SE & Co. KGaA, Glenmark Pharmaceuticals Limited, B. Braun Melsungen AG, Pacira BioSciences Inc., Pfizer Inc., Septodont, Teva Pharmaceutical Industries Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Mylan N.V., Akorn Operating Company LLC, Endo International PLC, Abbott Laboratories, Anesiva Inc., Baxter International Inc., Dentsply Sirona Inc., Jiangsu Hengrui Medicine Co. Ltd., Johnson & Johnson, Lannett Company Inc., Lupin Limited, Alembic Pharmaceuticals, Torrent Pharmaceuticals, Cadila Healthcare, Indoco Remedies, Jubilant Life Sciences, Zydus Cadila, Wockhardt Ltd., Par Pharmaceutical, West-Ward Pharmaceuticals Corp.

North America was the largest region in the local anesthesia drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the local anesthesia drugs market report during the forecast period. The regions covered in the local anesthesia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the local anesthesia drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The local anesthesia drugs market consists of sales of propofol, etomidate, ketamine, and other types. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Local Anesthesia Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on local anesthesia drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for local anesthesia drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The local anesthesia drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Bupivacaine; Lidocaine; Benzocaine; Ropivacaine; Prilocaine; Chloroprocaine; Other Types
• 2) By Mode Of Administration: Injectable; Surface Anesthetic
• 3) By Distribution Channel: Hospital Pharmacy; Pharmacy Stores; Other Channels
• Subsegments:
• 1) By Bupivacaine: Injectable Formulations; Topical Formulations
• 2) By Lidocaine: Injectable Formulations; Topical Formulations; Transdermal Patches
• 3) By Benzocaine: Topical Gel; Ointments; Lozenges
• 4) By Ropivacaine: Injectable Formulations
• 5) By Prilocaine: Injectable Formulations; Topical Formulations
• 6) By Chloroprocaine: Injectable Formulations
• 7) By Other Types: Tetracaine; Procaine; Articaine
• Companies Mentioned: Hikma Pharmaceuticals PLC; Fresenius SE & Co. KGaA; Glenmark Pharmaceuticals Limited; B. Braun Melsungen AG; Pacira BioSciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Local Anesthesia Drugs Market Characteristics

3. Local Anesthesia Drugs Market Trends And Strategies

4. Local Anesthesia Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Local Anesthesia Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Local Anesthesia Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Local Anesthesia Drugs Market Growth Rate Analysis
• 5.4. Global Local Anesthesia Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Local Anesthesia Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Local Anesthesia Drugs Total Addressable Market (TAM)

6. Local Anesthesia Drugs Market Segmentation

• 6.1. Global Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bupivacaine
• Lidocaine
• Benzocaine
• Ropivacaine
• Prilocaine
• Chloroprocaine
• Other Types
• 6.2. Global Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Surface Anesthetic
• 6.3. Global Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Pharmacy Stores
• Other Channels
• 6.4. Global Local Anesthesia Drugs Market, Sub-Segmentation Of Bupivacaine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Topical Formulations
• 6.5. Global Local Anesthesia Drugs Market, Sub-Segmentation Of Lidocaine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Topical Formulations
• Transdermal Patches
• 6.6. Global Local Anesthesia Drugs Market, Sub-Segmentation Of Benzocaine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Gel
• Ointments
• Lozenges
• 6.7. Global Local Anesthesia Drugs Market, Sub-Segmentation Of Ropivacaine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• 6.8. Global Local Anesthesia Drugs Market, Sub-Segmentation Of Prilocaine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Topical Formulations
• 6.9. Global Local Anesthesia Drugs Market, Sub-Segmentation Of Chloroprocaine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• 6.10. Global Local Anesthesia Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetracaine
• Procaine
• Articaine

7. Local Anesthesia Drugs Market Regional And Country Analysis

• 7.1. Global Local Anesthesia Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Local Anesthesia Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Local Anesthesia Drugs Market

• 8.1. Asia-Pacific Local Anesthesia Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Local Anesthesia Drugs Market

• 9.1. China Local Anesthesia Drugs Market Overview
• 9.2. China Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Local Anesthesia Drugs Market

• 10.1. India Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Local Anesthesia Drugs Market

• 11.1. Japan Local Anesthesia Drugs Market Overview
• 11.2. Japan Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Local Anesthesia Drugs Market

• 12.1. Australia Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Local Anesthesia Drugs Market

• 13.1. Indonesia Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Local Anesthesia Drugs Market

• 14.1. South Korea Local Anesthesia Drugs Market Overview
• 14.2. South Korea Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Local Anesthesia Drugs Market

• 15.1. Western Europe Local Anesthesia Drugs Market Overview
• 15.2. Western Europe Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Local Anesthesia Drugs Market

• 16.1. UK Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Local Anesthesia Drugs Market

• 17.1. Germany Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Local Anesthesia Drugs Market

• 18.1. France Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Local Anesthesia Drugs Market

• 19.1. Italy Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Local Anesthesia Drugs Market

• 20.1. Spain Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Local Anesthesia Drugs Market

• 21.1. Eastern Europe Local Anesthesia Drugs Market Overview
• 21.2. Eastern Europe Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Local Anesthesia Drugs Market

• 22.1. Russia Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Local Anesthesia Drugs Market

• 23.1. North America Local Anesthesia Drugs Market Overview
• 23.2. North America Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Local Anesthesia Drugs Market

• 24.1. USA Local Anesthesia Drugs Market Overview
• 24.2. USA Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Local Anesthesia Drugs Market

• 25.1. Canada Local Anesthesia Drugs Market Overview
• 25.2. Canada Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Local Anesthesia Drugs Market

• 26.1. South America Local Anesthesia Drugs Market Overview
• 26.2. South America Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Local Anesthesia Drugs Market

• 27.1. Brazil Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Local Anesthesia Drugs Market

• 28.1. Middle East Local Anesthesia Drugs Market Overview
• 28.2. Middle East Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Local Anesthesia Drugs Market

• 29.1. Africa Local Anesthesia Drugs Market Overview
• 29.2. Africa Local Anesthesia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Local Anesthesia Drugs Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Local Anesthesia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Local Anesthesia Drugs Market Competitive Landscape And Company Profiles

• 30.1. Local Anesthesia Drugs Market Competitive Landscape
• 30.2. Local Anesthesia Drugs Market Company Profiles
  • 30.2.1. Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Glenmark Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pacira BioSciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Local Anesthesia Drugs Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Septodont
• 31.3. Teva Pharmaceutical Industries Limited
• 31.4. Aspen Pharmacare Holdings Limited
• 31.5. Sagent Pharmaceuticals Inc.
• 31.6. Mylan N.V.
• 31.7. Akorn Operating Company LLC
• 31.8. Endo International PLC
• 31.9. Abbott Laboratories
• 31.10. Anesiva Inc.
• 31.11. Baxter International Inc.
• 31.12. Dentsply Sirona Inc.
• 31.13. Jiangsu Hengrui Medicine Co. Ltd.
• 31.14. Johnson & Johnson
• 31.15. Lannett Company Inc.

32. Global Local Anesthesia Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Local Anesthesia Drugs Market

34. Recent Developments In The Local Anesthesia Drugs Market

35. Local Anesthesia Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Local Anesthesia Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Local Anesthesia Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Local Anesthesia Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer